Concepedia

Yifang Zou

YZ

Statistics

Publications

12

Citations

1K

H-Index

12

Active since

2019

Affiliations

Jilin University(Current)

Shuguang Hospital

Shanghai University of Traditional Chinese Medicine

First Hospital of Jilin University

University College Cork

Yifang Zou is an author at Jilin University specializing in oncology, nanoparticle drug delivery, and nanomedicine.

Publications per year

2019–2024

12

Publications

12

<scp>d</scp> -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

Shulan Han, Xueying Bao, Yifang Zou et al. · Science Advances · 2023 · 285 citations · Full text

Medicine, Immunology, Oncology +17

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

Dandan Sun, Yifang Zou, Shulan Han et al. · Acta Pharmaceutica Sinica B · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma

Jianfeng Guo, Zhuo Yu, Dandan Sun et al. · Molecular Cancer · 2021 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

A Low Molecular Weight Hyaluronic Acid Derivative Accelerates Excisional Wound Healing by Modulating Pro-Inflammation, Promoting Epithelialization and Neovascularization, and Remodeling Collagen

Yin Gao, Yao Sun, Hao Yang et al. · International Journal of Molecular Sciences · 2019 · 86 citations · Full text

Medicine, Dermatology, Surgery +17

Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer

Shulan Han, Shengnan Bi, Tingting Guo et al. · Journal of Controlled Release · 2022 · 81 citations

Pharmacy, Oncology, Pharmaceutics +16

1–5 of 12